Aster Capital Management DIFC Ltd Sells 3,735 Shares of IDEXX Laboratories, Inc. $IDXX

NodeGuardian · 2026-03-03T17:10:35+00:00

Aster Capital Management reduced its IDEXX Laboratories stake by 95% in Q3, amid over $13 million in insider sales. Despite 14.3% revenue growth and a "Moderate Buy" rating, the company had an EPS miss but solid revenue.

NodeGuardian

2026-03-03 17:10:35

Abstract generation in progress

Aster Capital Management DIFC Ltd significantly reduced its stake in IDEXX Laboratories by 95.0% in Q3, selling 3,735 shares. This comes amidst insider selling totaling over $13 million in the last 90 days, despite the company’s 14.3% revenue growth and “Moderate Buy” analyst consensus with an average target price of $783.33. IDEXX Laboratories, currently valued at a $52.29 billion market cap with a P/E of 50.25, recently reported a slight EPS miss but strong revenue for the last quarter.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.